|
YAF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.49980000535766E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07490002956945E-09 |
| Normal-vs-Stage2 |
1.254180E-02 |
| Normal-vs-Stage3 |
9.034900E-04 |
| Normal-vs-Stage4 |
1.061630E-03 |
| Stage1-vs-Stage2 |
3.475800E-01 |
| Stage1-vs-Stage3 |
8.751500E-02 |
| Stage1-vs-Stage4 |
9.262400E-01 |
| Stage2-vs-Stage3 |
7.883600E-01 |
| Stage2-vs-Stage4 |
4.632400E-01 |
| Stage3-vs-Stage4 |
2.232200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.49339999986087E-07 |
| Normal-vs-AfricanAmerican |
9.187500E-04 |
| Normal-vs-Asian |
9.430500E-04 |
| Caucasian-vs-AfricanAmerican |
3.849800E-02 |
| Caucasian-vs-Asian |
6.642400E-01 |
| AfricanAmerican-vs-Asian |
7.944200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.52079999996102E-06 |
| Normal-vs-Female |
1.64450000283978E-08 |
| Male-vs-Female |
7.447200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61970001247391E-09 |
| Normal-vs-Age(41-60Yrs) |
1.61602999999566E-05 |
| Normal-vs-Age(61-80Yrs) |
3.433200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.306000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.494620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.273500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.281200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.140400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.537800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.982500E-03 |
| Classical-VS-Follicular |
3.980800E-01 |
| Classical-VS-Other |
1.591960E-01 |
| Classical-VS-Normal |
6.48370002132026E-09 |
| Tall-VS-Follicular |
5.123700E-03 |
| Tall-VS-Other |
1.293210E-01 |
| Tall-VS-Normal |
1.026440E-01 |
| Follicular-VS-Other |
4.376400E-01 |
| Follicular-VS-Normal |
1.83795999999514E-05 |
| Other-VS-Normal |
6.692200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47429999999937E-05 |
| Normal-vs-N1 |
3.826600E-04 |
| N0-vs-N1 |
1.270410E-01 |
|
|
